This directory lists 94 pharmaceutical contract manufacturers across the United States, from early-stage development CDMOs (Contract Development and Manufacturing Organizations) specializing in formulation and analytical method development, to large-scale commercial manufacturers offering high-volume aseptic fill-finish capabilities.
Buyers engage these specialized partners to solve complex problems such as scaling up production from clinical batches to commercial volumes, ensuring consistent product quality through rigorous process validation, managing intricate global supply chains for Active Pharmaceutical Ingredients (APIs), and executing comprehensive stability studies for shelf-life determination. The breadth of services often extends to regulatory affairs support, including compiling Chemistry, Manufacturing, and Controls (CMC) sections for regulatory filings and managing serialization requirements for global markets.
The types of pharmaceutical contract manufacturers vary significantly by their core competencies. Some operate as full-service CDMOs, providing end-to-end development, clinical trial material production, and commercial manufacturing. Others function as pure Contract Manufacturing Organizations (CMOs), focusing primarily on executing established manufacturing processes. Specialized facilities cater to specific needs, such as sterile injectables, highly potent compounds, controlled substances requiring DEA registration, or advanced biologics, each demanding distinct infrastructure, containment strategies, and regulatory expertise.